BioCardia Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2010
Net Income	-11.57	-11.91	-12.62	-15	-14.71	-13.99	-12.31	-10.31	-6.7	0.23	Upgrade
Depreciation & Amortization	0.41	0.38	0.64	0.07	0.55	0.09	0.08	0.04	0.05	0	Upgrade
Share-Based Compensation	1.03	1.18	1.66	2.95	2.72	2.77	2.71	0.94	0.28	0	Upgrade
Other Operating Activities	0.16	-0.21	-0.04	-0.37	1.99	0.06	0.85	3.81	-0.66	-0.02	Upgrade
Operating Cash Flow	-9.97	-10.56	-10.37	-12.36	-9.45	-11.07	-8.67	-5.52	-7.02	0.21	Upgrade
Operating Cash Flow Growth	-	-	-	-	-	-	-	-	-	692.59%	Upgrade
Capital Expenditures	-0.01	-0.07	-0.12	-0.03	-0.15	-0.07	-0.14	0	-0.13	0	Upgrade
Acquisitions	0	0	0	0	0	0	0	19.02	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-0.1	-	-	Upgrade
Investing Cash Flow	-0.01	-0.07	-0.12	-0.03	-0.15	-0.07	-0.14	18.92	-0.13	0	Upgrade
Share Issuance / Repurchase	3.73	5.12	1.95	27.87	9.19	3.8	0.14	0.02	0.06	0	Upgrade
Debt Issued / Paid	0	0	0	0.51	0.63	0	0	4.37	7.44	0	Upgrade
Other Financing Activities	-	-	-	-0.16	-	-	-	-	0.03	-	Upgrade
Financing Cash Flow	3.73	5.12	1.95	28.21	9.82	3.8	0.14	4.4	7.52	0	Upgrade
Net Cash Flow	-6.26	-5.51	-8.54	15.82	0.23	-7.33	-8.66	17.8	0.37	0.21	Upgrade
Free Cash Flow	-9.99	-10.63	-10.48	-12.39	-9.59	-11.14	-8.81	-5.52	-7.15	0.21	Upgrade
Free Cash Flow Growth	-	-	-	-	-	-	-	-	-	692.59%	Upgrade
Free Cash Flow Margin	-2093.50%	-786.32%	-1032.71%	-8544.14%	-1350.85%	-1781.60%	-1838.62%	-958.68%	-790.71%	50.12%	Upgrade
Free Cash Flow Per Share	-0.47	-0.60	-0.62	-1.22	-1.70	-2.61	-2.08	-5.94	-41.23	0.10	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).